Cargando…

Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Fibrosis is the strongest predictor for disease-specific mortality in non-alcoholic fatty liver diseases (NAFLD), but the need for liver biopsy limits its diagnosis. We assessed the performance of plasma ficolin-2 (FCN-2) as a biomarker of fibrosis identified by an in silico discovery strategy. Two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giraudi, Pablo J., Salvoza, Noel, Bonazza, Deborah, Saitta, Carlo, Lombardo, Daniele, Casagranda, Biagio, de Manzini, Nicolò, Pollicino, Teresa, Raimondo, Giovanni, Tiribelli, Claudio, Palmisano, Silvia, Rosso, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911336/ https://www.ncbi.nlm.nih.gov/pubmed/35269955 http://dx.doi.org/10.3390/ijms23052813

Ejemplares similares

Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
por: Salvoza, Noel, et al.
Publicado: (2022)

Optimization of Point-Shear Wave Elastography by Skin-to-Liver Distance to Assess Liver Fibrosis in Patients Undergoing Bariatric Surgery
por: Giuffrè, Mauro, et al.
Publicado: (2020)

Diagnostic management of nonalcoholic fatty liver disease: a transformational period in the development of diagnostic and predictive tools—a narrative review
por: Rosso, Natalia, et al.
Publicado: (2021)

Positron Emission Tomography Scan Reveals an Unusual Source for Cervical Lymphadenopathy: Right Colon Cancer
por: Palmisano, Silvia, et al.
Publicado: (2011)

PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients
por: Saitta, Carlo, et al.
Publicado: (2017)

The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH)
por: Salvoza, Noel, et al.
Publicado: (2022)

Indications for upper gastrointestinal endoscopy before bariatric surgery: a multicenter study
por: Abdallah, Hussein, et al.
Publicado: (2022)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Human L-Ficolin (Ficolin-2) and Its Clinical Significance
por: Kilpatrick, David C., et al.
Publicado: (2012)

L-ficolin and H-ficolin in patients with Familial Mediterranean fever
por: Mkrtchyan, G, et al.
Publicado: (2015)

Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
por: Szala, Agnieszka, et al.
Publicado: (2013)

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
por: Salvoza, Noel C., et al.
Publicado: (2016)

Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2012)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH
por: Anfuso, Beatrice, et al.
Publicado: (2019)

Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer
por: Wang, Li-ting, et al.
Publicado: (2022)

Occult Hepatitis B Virus Infection: An Update
por: Saitta, Carlo, et al.
Publicado: (2022)

Association of ficolin‐1 and ficolin‐3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population
por: Li, Ye, et al.
Publicado: (2021)

Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases
por: Franzè, Maria Stella, et al.
Publicado: (2022)

Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Castelnuovo, Gabriele, et al.
Publicado: (2023)

Ficolin-1 and Ficolin-3 Plasma Levels Are Altered in HIV and HIV/HCV Coinfected Patients From Southern Brazil
por: Tizzot, Maria Regina, et al.
Publicado: (2018)

Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models
por: Cabral, Loraine Kay D., et al.
Publicado: (2023)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
por: Kazankov, Konstantin, et al.
Publicado: (2020)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Carbohydrate recognition and complement activation by rat ficolin-B
por: Girija, Umakhanth Venkatraman, et al.
Publicado: (2011)

The Interaction Pattern of Murine Serum Ficolin-A with Microorganisms
por: Hummelshøj, Tina, et al.
Publicado: (2012)

Functional Analysis of Ficolin-3 Mediated Complement Activation
por: Hein, Estrid, et al.
Publicado: (2010)

Structural and functional diversity of collectins and ficolins and their relationship to disease
por: Howard, Mark, et al.
Publicado: (2017)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Association of Ficolin-3 with Severity and Outcome of Chronic Heart Failure
por: Prohászka, Zoltán, et al.
Publicado: (2013)

Ficolin-1 is a promising therapeutic target for autoimmune diseases
por: Katayama, Michihito, et al.
Publicado: (2018)

Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever
por: Catarino, Sandra Jeremias, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4rbf71i6398fseoaat76354sd5